Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

13.70
Delayed Data
As of 3:30pm ET
 +0.15 / +1.11%
Today’s Change
10.75
Today|||52-Week Range
21.49
-22.60%
Year-to-Date
MedTech Industry Outlook - March 2017
Mar 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close13.55
Today’s open13.50
Day’s range13.35 - 13.75
Volume160,507
Average volume (3 months)407,691
Market cap$571.8M
Dividend yield3.65%
Data as of 3:30pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-17.68%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio19.6
Price/Sales4.17
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
ALRPRBAlere Inc0.000.00%
--Quidel Corp+0.29+1.47%
LNTHLantheus Holdings In...+0.03+0.21%
CLDXCelldex Therapeutics...+0.31+8.97%
Data as of 3:46pm ET, 03/29/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.19
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John A. Kraeutler
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts


Search for Jobs